Evidence map›Paper›PMID 37242104›Full record

ReviewNanomaterials (Basel, Switzerland)2023

Exploring the Versatility of Microemulsions in Cutaneous Drug Delivery: Opportunities and Challenges.

Zouhair Ait-Touchente, Nadia Zine, Nicole Jaffrezic-Renault, Abdelhamid Errachid, Noureddine Lebaz, Hatem Fessi, Abdelhamid Elaissari

Open access · goldAbstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 59 citations in OpenAlex.

  1. Advances in carrier-free nanodrug delivery systems.Drug delivery and translational research · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zouhair Ait-TouchenteUniv Lyon, Université Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, 69100 Villeurbanne, France.
Nadia ZineUniv Lyon, Université Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, 69100 Villeurbanne, France.
Nicole Jaffrezic-RenaultUniv Lyon, Université Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, 69100 Villeurbanne, France.ORCID 0000-0003-1354-9273
Abdelhamid ErrachidUniv Lyon, Université Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, 69100 Villeurbanne, France.
Noureddine LebazUniv Lyon, Université Claude Bernard Lyon-1, CNRS, LAGEPP UMR 5007, 69100 Villeurbanne, France.ORCID 0000-0001-7116-8554
Hatem FessiUniv Lyon, Université Claude Bernard Lyon-1, CNRS, LAGEPP UMR 5007, 69100 Villeurbanne, France.
Abdelhamid ElaissariUniv Lyon, Université Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, 69100 Villeurbanne, France.ORCID 0000-0002-2151-9894
Université Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microemulsions are novel drug delivery systems that have garnered significant attention in the pharmaceutical research field. These systems possess several desirable characteristics, such as transparency and thermodynamic stability, which make them suitable for delivering both hydrophilic and hydrophobic drugs. In this comprehensive review, we aim to explore different aspects related to the formulation, characterization, and applications of microemulsions, with a particular emphasis on their potential for cutaneous drug delivery. Microemulsions have shown great promise in overcoming bioavailability concerns and enabling sustained drug delivery. Thus, it is crucial to have a thorough understanding of their formulation and characterization in order to optimize their effectiveness and safety. This review will delve into the different types of microemulsions, their composition, and the factors that affect their stability. Furthermore, the potential of microemulsions as drug delivery systems for skin applications will be discussed. Overall, this review will provide valuable insights into the advantages of microemulsions as drug delivery systems and their potential for improving cutaneous drug delivery.

Indexed as

cutaneous drug deliverydrug deliverymicroemulsion bioavailabilitymicroemulsions systemsskin penetration

Identifiers

PMID37242104
PMCPMC10222322
OpenAlexW4377294763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.